{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,5]],"date-time":"2026-09-05T05:47:26Z","timestamp":1788587246795,"version":"build-2803163510"},"reference-count":107,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["ard.eular.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Annals of the Rheumatic Diseases"],"published-print":{"date-parts":[[2024,7]]},"DOI":"10.1136\/ard-2023-224103","type":"journal-article","created":{"date-parts":[[2024,2,20]],"date-time":"2024-02-20T18:25:20Z","timestamp":1708453520000},"page":"838-846","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":15,"title":["Immune response to post-translationally modified proteins in rheumatoid arthritis: what makes it special?"],"prefix":"10.1016","volume":"83","author":[{"given":"Diane","family":"van der Woude","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ren\u00e9 E M","family":"Toes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1136\/ard-2023-224103_bib2","first-page":"969","article-title":"Prevalence and significance of anti-peptidylarginine deiminase 4 antibodies in rheumatoid arthritis","volume":"35","author":"Zhao","year":"2008","journal-title":"J Rheumatol"},{"key":"10.1136\/ard-2023-224103_bib3","article-title":"Diagnostic values, association with disease activity and possible risk factors of anti-PAD4 in rheumatoid arthritis: a meta-analysis","author":"Zhang","year":"2023","journal-title":"Rheumatology (Oxford)"},{"key":"10.1136\/ard-2023-224103_bib4","doi-asserted-by":"crossref","DOI":"10.3389\/fneur.2022.874211","article-title":"Peptidylarginine deiminase 2 autoantibodies are linked to less severe disease in multiple sclerosis and post-treatment lyme disease","volume":"13","author":"Kim","year":"2022","journal-title":"Front Neurol"},{"key":"10.1136\/ard-2023-224103_bib5","article-title":"Anti-Peptidylarginine deiminase 4 autoantibodies and disease duration as predictors of treatment response in rheumatoid arthritis","volume":"13","author":"Cappelli","year":"2023","journal-title":"ACR Open Rheumatol"},{"key":"10.1136\/ard-2023-224103_bib6","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.3005370","article-title":"Erosive rheumatoid arthritis is associated with antibodies that activate PAD4 by increasing calcium sensitivity","volume":"5","author":"Darrah","year":"2013","journal-title":"Sci Transl Med"},{"key":"10.1136\/ard-2023-224103_bib7","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1136\/annrheumdis-2017-211489","article-title":"Affinity maturation shapes the function of agonistic antibodies to peptidylarginine deiminase type 4 in rheumatoid arthritis","volume":"77","author":"Shi","year":"2018","journal-title":"Ann Rheum Dis"},{"key":"10.1136\/ard-2023-224103_bib8","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.jaut.2017.06.004","article-title":"Autoreactivity to malondialdehyde-modifications in rheumatoid arthritis is linked to disease activity and synovial pathogenesis","volume":"84","author":"Gr\u00f6nwall","year":"2017","journal-title":"J Autoimmun"},{"key":"10.1136\/ard-2023-224103_bib9","doi-asserted-by":"crossref","DOI":"10.1136\/rmdopen-2023-003480","article-title":"Antibodies against advanced glycation end-products and malondialdehyde-acetaldehyde adducts identify a new specific subgroup of hitherto patients with seronegative arthritis with a distinct clinical phenotype and an HLA class II association","volume":"9","author":"van den Beukel","year":"2023","journal-title":"RMD Open"},{"key":"10.1136\/ard-2023-224103_bib10","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/S0021-9150(98)00153-1","article-title":"Association of malondialdehyde-acetaldehyde (MAA) adducted proteins with atherosclerotic-induced vascular inflammatory injury","volume":"141","author":"Hill","year":"1998","journal-title":"Atherosclerosis"},{"key":"10.1136\/ard-2023-224103_bib11","doi-asserted-by":"crossref","first-page":"878","DOI":"10.1053\/he.2000.5373","article-title":"Detection of circulating antibodies against malondialdehyde-acetaldehyde adducts in patients with alcohol-induced liver disease","volume":"31","author":"Rolla","year":"2000","journal-title":"Hepatology"},{"key":"10.1136\/ard-2023-224103_bib12","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1016\/j.jvs.2014.08.117","article-title":"Antibodies against malondialdehyde-acetaldehyde adducts can help identify patients with abdominal aortic aneurysm","volume":"63","author":"Carson","year":"2016","journal-title":"J Vasc Surg"},{"key":"10.1136\/ard-2023-224103_bib13","doi-asserted-by":"crossref","first-page":"3433","DOI":"10.1002\/art.21385","article-title":"Refining the complex rheumatoid arthritis phenotype based on specificity of the HLA-DRB1 shared epitope for antibodies to citrullinated proteins","volume":"52","author":"Huizinga","year":"2005","journal-title":"Arthritis Rheum"},{"key":"10.1136\/ard-2023-224103_bib14","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1038\/ng1206","article-title":"Functional haplotypes of PADI4, encoding citrullinating enzyme peptidylarginine deiminase 4, are associated with rheumatoid arthritis","volume":"34","author":"Suzuki","year":"2003","journal-title":"Nat Genet"},{"key":"10.1136\/ard-2023-224103_bib15","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1136\/annrheumdis-2019-216499","article-title":"Antibodies and B cells recognising citrullinated proteins display a broad cross-reactivity towards other post-translational modifications","volume":"79","author":"Kissel","year":"2020","journal-title":"Ann Rheum Dis"},{"key":"10.1136\/ard-2023-224103_bib16","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1002\/art.40699","article-title":"Recognition of amino acid motifs, rather than specific proteins, by human plasma cell-derived monoclonal antibodies to posttranslationally modified proteins in rheumatoid arthritis","volume":"71","author":"Steen","year":"2019","journal-title":"Arthritis Rheumatol"},{"key":"10.1136\/ard-2023-224103_bib17","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1038\/s41584-019-0244-4","article-title":"The structure, specificity and function of anti-citrullinated protein antibodies","volume":"15","author":"Ge","year":"2019","journal-title":"Nat Rev Rheumatol"},{"key":"10.1136\/ard-2023-224103_bib18","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1002\/art.40698","article-title":"Structural basis of cross-reactivity of anti-citrullinated protein antibodies","volume":"71","author":"Ge","year":"2019","journal-title":"Arthritis Rheumatol"},{"key":"10.1136\/ard-2023-224103_bib19","doi-asserted-by":"crossref","first-page":"17372","DOI":"10.1073\/pnas.1114465108","article-title":"Autoantibodies recognizing carbamylated proteins are present in sera of patients with rheumatoid arthritis and predict joint damage","volume":"108","author":"Shi","year":"2011","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1136\/ard-2023-224103_bib20","doi-asserted-by":"crossref","first-page":"1761","DOI":"10.1136\/annrheumdis-2013-205109","article-title":"Anti-CarP antibodies in two large cohorts of patients with rheumatoid arthritis and their relationship to genetic risk factors, cigarette smoking and other autoantibodies","volume":"73","author":"Jiang","year":"2014","journal-title":"Ann Rheum Dis"},{"key":"10.1136\/ard-2023-224103_bib21","doi-asserted-by":"crossref","first-page":"908","DOI":"10.1136\/annrheumdis-2018-214950","article-title":"Different classes of anti-modified protein antibodies are induced on exposure to antigens expressing only one type of modification","volume":"78","author":"Kampstra","year":"2019","journal-title":"Ann Rheum Dis"},{"key":"10.1136\/ard-2023-224103_bib22","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1136\/annrheumdis-2014-206785","article-title":"Identification of novel antiacetylated vimentin antibodies in patients with early inflammatory arthritis","volume":"75","author":"Juarez","year":"2016","journal-title":"Ann Rheum Dis"},{"key":"10.1136\/ard-2023-224103_bib23","doi-asserted-by":"crossref","first-page":"1643","DOI":"10.1002\/art.41385","article-title":"Different Hierarchies of anti-modified protein autoantibody reactivities in rheumatoid arthritis","volume":"72","author":"Sahlstr\u00f6m","year":"2020","journal-title":"Arthritis Rheumatol"},{"key":"10.1136\/ard-2023-224103_bib24","doi-asserted-by":"crossref","DOI":"10.1177\/1759720X211022533","article-title":"Presence of anti-acetylated peptide antibodies (AAPA) in inflammatory arthritis and other rheumatic diseases suggests discriminative diagnostic capacity towards early rheumatoid arthritis","volume":"13","author":"Studenic","year":"2021","journal-title":"Ther Adv Musculoskelet Dis"},{"key":"10.1136\/ard-2023-224103_bib25","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1136\/ard-2023-224553","article-title":"Igm antibodies against acetylated proteins as a possible starting point of the anti-modified protein antibody response in rheumatoid arthritis","volume":"83","author":"van Wesemael","year":"2024","journal-title":"Ann Rheum Dis"},{"key":"10.1136\/ard-2023-224103_bib26","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1186\/s13075-021-02609-5","article-title":"Cross-reactivity of IgM anti-modified protein antibodies in rheumatoid arthritis despite limited mutational load","volume":"23","author":"Reijm","year":"2021","journal-title":"Arthritis Res Ther"},{"key":"10.1136\/ard-2023-224103_bib27","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1172\/jci.insight.172006","article-title":"Autoreactive B cells in rheumatoid arthritis include mainly activated CXCR3+ memory B cells and plasmablasts","volume":"8","author":"Reijm","year":"2023","journal-title":"JCI Insight"},{"key":"10.1136\/ard-2023-224103_bib28","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1126\/scitranslmed.aaz5327","article-title":"Persistently activated, proliferative memory autoreactive B cells promote inflammation in rheumatoid arthritis","volume":"12","author":"Kristyanto","year":"2020","journal-title":"Sci Transl Med"},{"key":"10.1136\/ard-2023-224103_bib29","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2204607119","article-title":"Early human B cell signatures of the primary antibody response to mRNA vaccination","volume":"119","author":"Kardava","year":"2022","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1136\/ard-2023-224103_bib30","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1136\/annrheumdis-2011-200990","article-title":"EULAR recommendations for terminology and research in individuals at risk of rheumatoid arthritis: report from the Study Group for Risk Factors for Rheumatoid Arthritis","volume":"71","author":"Gerlag","year":"2012","journal-title":"Ann Rheum Dis"},{"key":"10.1136\/ard-2023-224103_bib31","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1146\/annurev.immunol.26.021607.090244","article-title":"Immunity to citrullinated proteins in rheumatoid arthritis","volume":"26","author":"Klareskog","year":"2008","journal-title":"Annu Rev Immunol"},{"key":"10.1136\/ard-2023-224103_bib32","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.1136\/annrheumdis-2021-221754","article-title":"Multiomics analysis of rheumatoid arthritis yields sequence variants that have large effects on risk of the seropositive subset","volume":"81","author":"Saevarsdottir","year":"2022","journal-title":"Ann Rheum Dis"},{"key":"10.1136\/ard-2023-224103_bib33","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1136\/annrheumdis-2018-213678","article-title":"Genetics of rheumatoid arthritis: 2018 status","volume":"78","author":"Okada","year":"2019","journal-title":"Ann Rheum Dis"},{"key":"10.1136\/ard-2023-224103_bib34","doi-asserted-by":"crossref","first-page":"1044","DOI":"10.1086\/498651","article-title":"Replication of putative candidate-gene associations with rheumatoid arthritis in >4,000 samples from North America and Sweden: association of susceptibility with PTPN22, CTLA4, and PADI4","volume":"77","author":"Plenge","year":"2005","journal-title":"Am J Hum Genet"},{"key":"10.1136\/ard-2023-224103_bib35","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1002\/art.41630","article-title":"HLA-B*08 identified as the most prominently associated major histocompatibility complex locus for anti-carbamylated protein antibody-positive\/anti-cyclic citrullinated peptide-negative rheumatoid arthritis","volume":"73","author":"Regueiro","year":"2021","journal-title":"Arthritis Rheumatol"},{"key":"10.1136\/ard-2023-224103_bib36","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.berh.2017.08.003","article-title":"Genetic and environmental risk factors for rheumatoid arthritis","volume":"31","author":"Deane","year":"2017","journal-title":"Best Pract Res Clin Rheumatol"},{"key":"10.1136\/ard-2023-224103_bib37","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1002\/art.41559","article-title":"Association of agricultural, occupational, and military inhalants with autoantibodies and disease features in US veterans with rheumatoid arthritis","volume":"73","author":"Ebel","year":"2021","journal-title":"Arthritis Rheumatol"},{"key":"10.1136\/ard-2023-224103_bib38","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1136\/ard.2004.022053","article-title":"Silica exposure is associated with increased risk of developing rheumatoid arthritis: results from the Swedish EIRA study","volume":"64","author":"Stolt","year":"2005","journal-title":"Ann Rheum Dis"},{"key":"10.1136\/ard-2023-224103_bib39","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1086\/516736","article-title":"Gene-gene and gene-environment interactions involving HLA-DRB1, PTPN22, and smoking in two subsets of rheumatoid arthritis","volume":"80","author":"Kallberg","year":"2007","journal-title":"Am J Hum Genet"},{"key":"10.1136\/ard-2023-224103_bib40","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1002\/art.21575","article-title":"A new model for an etiology of rheumatoid arthritis: smoking may trigger HLA-DR (shared epitope)-restricted immune reactions to autoantigens modified by citrullination","volume":"54","author":"Klareskog","year":"2006","journal-title":"Arthritis Rheum"},{"key":"10.1136\/ard-2023-224103_bib41","doi-asserted-by":"crossref","first-page":"1488","DOI":"10.1136\/ard.2007.075192","article-title":"Smoking increases peptidylarginine deiminase 2 enzyme expression in human lungs and increases citrullination in BAL cells","volume":"67","author":"Makrygiannakis","year":"2008","journal-title":"Ann Rheum Dis"},{"key":"10.1136\/ard-2023-224103_bib42","doi-asserted-by":"crossref","first-page":"1910","DOI":"10.1002\/art.42549","article-title":"Rheumatoid arthritis-specific autoimmunity in the lung before and at the onset of disease","volume":"75","author":"Joshua","year":"2023","journal-title":"Arthritis Rheumatol"},{"key":"10.1136\/ard-2023-224103_bib43","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1002\/art.40401","article-title":"Antibody responses to citrullinated and noncitrullinated antigens in the sputum of subjects with rheumatoid arthritis and subjects at risk for development of rheumatoid arthritis","volume":"70","author":"Demoruelle","year":"2018","journal-title":"Arthritis Rheumatol"},{"key":"10.1136\/ard-2023-224103_bib44","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1136\/annrheumdis-2019-216709","article-title":"Anti-carbamylated proteins antibody repertoire in rheumatoid arthritis: evidence of a new autoantibody linked to interstitial lung disease","volume":"79","author":"Castellanos-Moreira","year":"2020","journal-title":"Ann Rheum Dis"},{"key":"10.1136\/ard-2023-224103_bib45","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1038\/s41584-018-0070-0","article-title":"Rheumatoid arthritis and the mucosal origins hypothesis: protection turns to destruction","volume":"14","author":"Holers","year":"2018","journal-title":"Nat Rev Rheumatol"},{"key":"10.1136\/ard-2023-224103_bib46","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1097\/BOR.0b013e32835fb8ec","article-title":"Periodontal disease and rheumatoid arthritis: the evidence accumulates for complex pathobiologic interactions","volume":"25","author":"Bingham","year":"2013","journal-title":"Curr Opin Rheumatol"},{"key":"10.1136\/ard-2023-224103_bib47","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.abq8476","article-title":"Oral mucosal breaks trigger anti-citrullinated bacterial and human protein antibody responses in rheumatoid arthritis","volume":"15","author":"Brewer","year":"2023","journal-title":"Sci Transl Med"},{"key":"10.1136\/ard-2023-224103_bib48","article-title":"Widespread protein lysine acetylation in gut microbiome and its alterations in patients with Crohn\u2019s disease","volume":"11","author":"Zhang","year":"2020","journal-title":"Nat Commun"},{"key":"10.1136\/ard-2023-224103_bib49","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1016\/j.chom.2021.03.020","article-title":"Individuals at risk for rheumatoid arthritis harbor differential intestinal bacteriophage communities with distinct metabolic potential","volume":"29","author":"Mangalea","year":"2021","journal-title":"Cell Host Microbe"},{"key":"10.1136\/ard-2023-224103_bib50","doi-asserted-by":"crossref","first-page":"1376","DOI":"10.1016\/j.immuni.2023.04.003","article-title":"Phage display sequencing reveals that genetic, environmental, and intrinsic factors influence variation of human antibody epitope repertoire","volume":"56","author":"Andreu-S\u00e1nchez","year":"2023","journal-title":"Immunity"},{"key":"10.1136\/ard-2023-224103_bib51","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1126\/scitranslmed.abn5166","article-title":"Clonal IgA and IgG autoantibodies from individuals at risk for rheumatoid arthritis identify an arthritogenic strain of Subdoligranulum","volume":"14","author":"Chriswell","year":"2022","journal-title":"Sci Transl Med"},{"key":"10.1136\/ard-2023-224103_bib52","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1136\/annrheumdis-2013-203947","article-title":"Environmental and genetic factors in the development of anticitrullinated protein antibodies (ACPAs) and ACPA-positive rheumatoid arthritis: an epidemiological investigation in twins","volume":"74","author":"Hensvold","year":"2015","journal-title":"Ann Rheum Dis"},{"key":"10.1136\/ard-2023-224103_bib53","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1136\/annrheumdis-2021-220546","article-title":"Determining in which pre-arthritis stage HLA-shared epitope alleles and smoking exert their effect on the development of rheumatoid arthritis","volume":"81","author":"Wouters","year":"2022","journal-title":"Ann Rheum Dis"},{"key":"10.1136\/ard-2023-224103_bib54","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1002\/art.20018","article-title":"Specific autoantibodies precede the symptoms of rheumatoid arthritis: A study of serial measurements in blood donors","volume":"50","author":"Nielen","year":"2004","journal-title":"Arthritis Rheum"},{"key":"10.1136\/ard-2023-224103_bib55","doi-asserted-by":"crossref","first-page":"2741","DOI":"10.1002\/art.11223","article-title":"Antibodies against cyclic citrullinated peptide and IgA rheumatoid factor predict the development of rheumatoid arthritis","volume":"48","author":"Rantap\u00e4\u00e4-Dahlqvist","year":"2003","journal-title":"Arthritis Rheum"},{"key":"10.1136\/ard-2023-224103_bib56","doi-asserted-by":"crossref","first-page":"3226","DOI":"10.1002\/art.30537","article-title":"Development of the anti-citrullinated protein antibody repertoire prior to the onset of rheumatoid arthritis","volume":"63","author":"van de Stadt","year":"2011","journal-title":"Arthritis Rheum"},{"key":"10.1136\/ard-2023-224103_bib57","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1186\/s13075-016-0940-2","article-title":"Rheumatoid factor isotypes in relation to antibodies against citrullinated peptides and carbamylated proteins before the onset of rheumatoid arthritis","volume":"18","author":"Brink","year":"2016","journal-title":"Arthritis Res Ther"},{"key":"10.1136\/ard-2023-224103_bib58","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1002\/art.41091","article-title":"Timing of elevations of autoantibody isotypes prior to diagnosis of rheumatoid arthritis","volume":"72","author":"Kelmenson","year":"2020","journal-title":"Arthritis Rheumatol"},{"key":"10.1136\/ard-2023-224103_bib59","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1002\/art.42098","article-title":"IgG anti-citrullinated protein antibody variable domain glycosylation increases before the onset of rheumatoid arthritis and stabilizes thereafter: a cross-sectional study encompassing ~1,500 samples","volume":"74","author":"Kissel","year":"2022","journal-title":"Arthritis Rheumatol"},{"key":"10.1136\/ard-2023-224103_bib60","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1186\/s13075-019-1815-0","article-title":"In rheumatoid arthritis, changes in autoantibody levels reflect intensity of immunosuppression, not subsequent treatment response","volume":"21","author":"de Moel","year":"2019","journal-title":"Arthritis Res Ther"},{"key":"10.1136\/ard-2023-224103_bib61","doi-asserted-by":"crossref","first-page":"1494","DOI":"10.1002\/art.40880","article-title":"A prospective study of the development of inflammatory arthritis in the family members of indigenous North American people with rheumatoid arthritis","volume":"71","author":"Tanner","year":"2019","journal-title":"Arthritis Rheumatol"},{"key":"10.1136\/ard-2023-224103_bib62","doi-asserted-by":"crossref","first-page":"1646","DOI":"10.1016\/j.jaci.2022.10.035","article-title":"Differences in IgG autoantibody Fab glycosylation across autoimmune diseases","volume":"151","author":"Koers","year":"2023","journal-title":"J Allergy Clin Immunol"},{"key":"10.1136\/ard-2023-224103_bib63","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1136\/annrheumdis-2014-206598","article-title":"Extensive glycosylation of ACPA-IgG variable domains modulates binding to citrullinated antigens in rheumatoid arthritis","volume":"75","author":"Rombouts","year":"2016","journal-title":"Ann Rheum Dis"},{"key":"10.1136\/ard-2023-224103_bib64","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1074\/mcp.M116.062919","article-title":"Structural analysis of variable domain glycosylation of anti-citrullinated protein antibodies in rheumatoid arthritis reveals the presence of highly sialylated glycans","volume":"16","author":"Hafkenscheid","year":"2017","journal-title":"Mol Cell Proteomics"},{"key":"10.1136\/ard-2023-224103_bib65","doi-asserted-by":"crossref","first-page":"1626","DOI":"10.1002\/art.40920","article-title":"N-linked glycans in the variable domain of igg anti-citrullinated protein antibodies predict the development of rheumatoid arthritis","volume":"71","author":"Hafkenscheid","year":"2019","journal-title":"Arthritis Rheumatol"},{"key":"10.1136\/ard-2023-224103_bib66","doi-asserted-by":"crossref","first-page":"1616","DOI":"10.1136\/annrheumdis-2019-215698","article-title":"On the presence of HLA-SE alleles and ACPA-IgG variable domain glycosylation in the phase preceding the development of rheumatoid arthritis","volume":"78","author":"Kissel","year":"2019","journal-title":"Ann Rheum Dis"},{"key":"10.1136\/ard-2023-224103_bib67","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1136\/annrheumdis-2021-220841","article-title":"Genetic predisposition (HLA-SE) is associated with ACPA-IgG variable domain glycosylation in the predisease phase of RA","volume":"81","author":"Kissel","year":"2022","journal-title":"Ann Rheum Dis"},{"key":"10.1136\/ard-2023-224103_bib68","doi-asserted-by":"crossref","first-page":"956","DOI":"10.1136\/annrheumdis-2017-212052","article-title":"B-cell receptor sequencing of anti-citrullinated protein antibody (ACPA) IgG-expressing B cells indicates a selective advantage for the introduction of N-glycosylation sites during somatic hypermutation","volume":"77","author":"Vergroesen","year":"2018","journal-title":"Ann Rheum Dis"},{"key":"10.1136\/ard-2023-224103_bib69","doi-asserted-by":"crossref","first-page":"1818","DOI":"10.1002\/acr.22385","article-title":"Effects of smoking and shared epitope on the production of anti-citrullinated peptide antibody in a Japanese adult population","volume":"66","author":"Terao","year":"2014","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"10.1136\/ard-2023-224103_bib70","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.abm1759","article-title":"Surface Ig variable domain glycosylation affects autoantigen binding and acts as threshold for human autoreactive B cell activation","volume":"8","author":"Kissel","year":"2022","journal-title":"Sci Adv"},{"key":"10.1136\/ard-2023-224103_bib71","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/j.chom.2019.05.003","article-title":"Pathogenic autoreactive T and B cells cross-react with mimotopes expressed by a common human gut commensal to trigger autoimmunity","volume":"26","author":"Ruff","year":"2019","journal-title":"Cell Host Microbe"},{"key":"10.1136\/ard-2023-224103_bib72","doi-asserted-by":"crossref","first-page":"1156","DOI":"10.1126\/science.aar7201","article-title":"Translocation of a gut pathobiont drives autoimmunity in mice and humans","volume":"359","author":"Manfredo Vieira","year":"2018","journal-title":"Science"},{"key":"10.1136\/ard-2023-224103_bib73","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1002\/art.25059","article-title":"Identification of citrullinated vimentin peptides as T cell epitopes in HLA-DR4-positive patients with rheumatoid arthritis","volume":"62","author":"Feitsma","year":"2010","journal-title":"Arthritis Rheum"},{"key":"10.1136\/ard-2023-224103_bib74","doi-asserted-by":"crossref","first-page":"2873","DOI":"10.1002\/art.30445","article-title":"Identification and functional characterization of T cells reactive to citrullinated vimentin in HLA-DRB1*0401-positive humanized mice and rheumatoid arthritis patients","volume":"63","author":"Snir","year":"2011","journal-title":"Arthritis Rheum"},{"key":"10.1136\/ard-2023-224103_bib75","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1186\/s12865-020-00357-w","article-title":"Multi-HLA class II tetramer analyses of citrulline-reactive T cells and early treatment response in rheumatoid arthritis","volume":"21","author":"Gerstner","year":"2020","journal-title":"BMC Immunol"},{"key":"10.1136\/ard-2023-224103_bib76","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1186\/s13075-016-1153-4","article-title":"The increased ability to present citrullinated peptides is not unique to HLA-SE molecules: arginine-to-citrulline conversion also enhances peptide affinity for HLA-DQ molecules","volume":"18","author":"Kampstra","year":"2016","journal-title":"Arthritis Res Ther"},{"key":"10.1136\/ard-2023-224103_bib77","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.764462","article-title":"Citrullinated Epitopes Identified on Tumour MHC Class II by Peptide Elution Stimulate Both Regulatory and Th1 Responses and Require Careful Selection for Optimal Anti-Tumour Responses","volume":"12","author":"Symonds","year":"2021","journal-title":"Front Immunol"},{"key":"10.1136\/ard-2023-224103_bib78","doi-asserted-by":"crossref","DOI":"10.1016\/j.jaut.2023.103092","article-title":"Citrullination of myelin basic protein induces a Th17-cell response in healthy individuals and enhances the presentation of MBP85-99 in patients with multiple sclerosis","volume":"139","author":"Mart\u00edn Monreal","year":"2023","journal-title":"Journal of Autoimmunity"},{"key":"10.1136\/ard-2023-224103_bib79","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2020-000560","article-title":"Combination vaccine based on citrullinated vimentin and enolase peptides induces potent CD4-mediated anti-tumor responses","volume":"8","author":"Brentville","year":"2020","journal-title":"J Immunother Cancer"},{"key":"10.1136\/ard-2023-224103_bib80","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.145217","article-title":"Shared recognition of citrullinated tenascin-C peptides by T and B cells in rheumatoid arthritis","volume":"6","author":"Song","year":"2021","journal-title":"JCI Insight"},{"key":"10.1136\/ard-2023-224103_bib81","doi-asserted-by":"crossref","DOI":"10.1002\/eji.202350402","article-title":"MHC I tetramer staining tends to overestimate the number of functionally relevant self-reactive CD8 T cells in the preimmune repertoire","volume":"53","author":"Pircher","year":"2023","journal-title":"Eur J Immunol"},{"key":"10.1136\/ard-2023-224103_bib82","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1126\/science.aay3037","article-title":"Autoimmunity provoked by foreign antigens","volume":"368","author":"Iversen","year":"2020","journal-title":"Science"},{"key":"10.1136\/ard-2023-224103_bib83","doi-asserted-by":"crossref","first-page":"2145","DOI":"10.1093\/rheumatology\/kex340","article-title":"The risk of individual autoantibodies, autoantibody combinations and levels for arthritis development in clinically suspect arthralgia","volume":"56","author":"Ten Brinck","year":"2017","journal-title":"Rheumatology (Oxford)"},{"key":"10.1136\/ard-2023-224103_bib84","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1002\/art.22380","article-title":"A prediction rule for disease outcome in patients with recent-onset undifferentiated arthritis: how to guide individual treatment decisions","volume":"56","author":"van der Helm-van Mil","year":"2007","journal-title":"Arthritis Rheum"},{"key":"10.1136\/ard-2023-224103_bib85","doi-asserted-by":"crossref","first-page":"R949","DOI":"10.1186\/ar1767","article-title":"Antibodies to citrullinated proteins and differences in clinical progression of rheumatoid arthritis","volume":"7","author":"van der Helm-van Mil","year":"2005","journal-title":"Arthritis Res Ther"},{"key":"10.1136\/ard-2023-224103_bib86","doi-asserted-by":"crossref","first-page":"2262","DOI":"10.1002\/art.24661","article-title":"Prevalence of and predictive factors for sustained disease-modifying antirheumatic drug-free remission in rheumatoid arthritis: results from two large early arthritis cohorts","volume":"60","author":"van der Woude","year":"2009","journal-title":"Arthritis Rheum"},{"key":"10.1136\/ard-2023-224103_bib87","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1007\/s40674-020-00160-z","article-title":"Rheumatoid arthritis-associated interstitial lung disease: Current update on prevalence, risk factors, and pharmacologic treatment","volume":"6","author":"Huang","year":"2020","journal-title":"Curr Treatm Opt Rheumatol"},{"key":"10.1136\/ard-2023-224103_bib88","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1136\/annrheumdis-2016-209794","article-title":"Rheumatoid arthritis phenotype at presentation differs depending on the number of autoantibodies present","volume":"76","author":"Derksen","year":"2017","journal-title":"Ann Rheum Dis"},{"key":"10.1136\/ard-2023-224103_bib89","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1093\/rheumatology\/key263","article-title":"Autoantibody status is not associated with early treatment response to first-line methotrexate in patients with early rheumatoid arthritis","volume":"58","author":"Dekkers","year":"2019","journal-title":"Rheumatology (Oxford)"},{"key":"10.1136\/ard-2023-224103_bib90","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1186\/s13075-018-1520-4","article-title":"Baseline autoantibody profile in rheumatoid arthritis is associated with early treatment response but not long-term outcomes","volume":"20","author":"de Moel","year":"2018","journal-title":"Arthritis Res Ther"},{"key":"10.1136\/ard-2023-224103_bib91","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/S0140-6736(22)01193-X","article-title":"Intervention with methotrexate in patients with arthralgia at risk of rheumatoid arthritis to reduce the development of persistent arthritis and its disease burden (TREAT EARLIER): a randomised, double-blind, placebo-controlled, proof-of-concept trial","volume":"400","author":"Krijbolder","year":"2022","journal-title":"Lancet"},{"key":"10.1136\/ard-2023-224103_bib92","first-page":"1","article-title":"Op0130\u2005ABATACEPT in individuals at risk of developing rheumatoid arthritis: results from the arthritis prevention in the pre-clinical phase of RA with ABATACEPT (Apippra) trial","volume":"82","author":"Cope","year":"2023","journal-title":"Ann Rheum Dis"},{"key":"10.1136\/ard-2023-224103_bib93","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1038\/s41584-023-01009-0","article-title":"Innate immune memory in inflammatory arthritis","volume":"19","author":"Jeljeli","year":"2023","journal-title":"Nat Rev Rheumatol"},{"key":"10.1136\/ard-2023-224103_bib94","doi-asserted-by":"crossref","first-page":"1002","DOI":"10.1016\/j.immuni.2021.03.003","article-title":"The complement system drives local inflammatory tissue priming by metabolic reprogramming of synovial fibroblasts","volume":"54","author":"Fri\u0161\u010di\u0107","year":"2021","journal-title":"Immunity"},{"key":"10.1136\/ard-2023-224103_bib95","doi-asserted-by":"crossref","first-page":"e316","DOI":"10.1016\/S2665-9913(22)00095-9","article-title":"Anti-citrullinated protein antibodies dominate the association of long-term outcomes and anti-modified protein antibodies in rheumatoid arthritis","volume":"4","author":"van Wesemael","year":"2022","journal-title":"Lancet Rheumatol"},{"key":"10.1136\/ard-2023-224103_bib96","doi-asserted-by":"crossref","first-page":"1259","DOI":"10.3899\/jrheum.120736","article-title":"Anticitrullinated protein antibodies and rheumatoid factor fluctuate in early inflammatory arthritis and do not predict clinical outcomes","volume":"40","author":"Barra","year":"2013","journal-title":"J Rheumatol"},{"key":"10.1136\/ard-2023-224103_bib97","doi-asserted-by":"crossref","first-page":"1836","DOI":"10.1136\/annrheumdis-2018-213823","article-title":"In RA, becoming seronegative over the first year of treatment does not translate to better chances of drug-free remission","volume":"77","author":"de Moel","year":"2018","journal-title":"Ann Rheum Dis"},{"key":"10.1136\/ard-2023-224103_bib98","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1002\/art.1780040105","article-title":"Transfusion studies in rheumatoid arthritis","volume":"4","author":"HARRIS","year":"1961","journal-title":"Arthritis Rheum"},{"key":"10.1136\/ard-2023-224103_bib99","doi-asserted-by":"crossref","first-page":"1124","DOI":"10.1056\/NEJM198305123081903","article-title":"Plasmapheresis therapy in rheumatoid arthritis","volume":"308","author":"Dwosh","year":"1983","journal-title":"N Engl J Med"},{"key":"10.1136\/ard-2023-224103_bib100","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1002\/art.23284","article-title":"Induction of macrophage secretion of tumor necrosis factor alpha through Fcgamma receptor IIa engagement by rheumatoid arthritis-specific autoantibodies to citrullinated proteins complexed with fibrinogen","volume":"58","author":"Clavel","year":"2008","journal-title":"Arthritis Rheum"},{"key":"10.1136\/ard-2023-224103_bib101","doi-asserted-by":"crossref","first-page":"1923","DOI":"10.1002\/art.24622","article-title":"Anti-cyclic citrullinated peptide antibodies from rheumatoid arthritis patients activate complement via both the classical and alternative pathways","volume":"60","author":"Trouw","year":"2009","journal-title":"Arthritis Rheum"},{"key":"10.1136\/ard-2023-224103_bib102","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1126\/scitranslmed.3005580","article-title":"NETs are a source of citrullinated autoantigens and stimulate inflammatory responses in rheumatoid arthritis","volume":"5","author":"Khandpur","year":"2013","journal-title":"Sci Transl Med"},{"key":"10.1136\/ard-2023-224103_bib103","doi-asserted-by":"crossref","DOI":"10.1136\/rmdopen-2020-001228","article-title":"Current view on the pathogenic role of anti-citrullinated protein antibodies in rheumatoid arthritis","volume":"7","author":"Catrina","year":"2021","journal-title":"RMD Open"},{"key":"10.1136\/ard-2023-224103_bib104","doi-asserted-by":"crossref","first-page":"1638","DOI":"10.1136\/ard-2023-224492","article-title":"Anti-cyclic Citrullinated peptide antibody and pain Sensitisation in patients with rheumatoid arthritis: a cross-sectional analysis","volume":"82","author":"Qiu","year":"2023","journal-title":"Ann Rheum Dis"},{"key":"10.1136\/ard-2023-224103_bib105","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1038\/s41467-023-36257-x","article-title":"A subset of antibodies targeting citrullinated proteins confers protection from rheumatoid arthritis","volume":"14","author":"He","year":"2023","journal-title":"Nat Commun"},{"key":"10.1136\/ard-2023-224103_bib106","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1136\/ard-2022-223417","article-title":"Divergent and dominant anti-inflammatory effects of patient-derived anticitrullinated protein antibodies (ACPA) in arthritis development","volume":"82","author":"Raposo","year":"2023","journal-title":"Ann Rheum Dis"},{"key":"10.1136\/ard-2023-224103_bib107","doi-asserted-by":"crossref","first-page":"1528","DOI":"10.1038\/s41423-020-0381-3","article-title":"Therapeutic ACPA inhibits NET formation: a potential therapy for neutrophil-mediated inflammatory diseases","volume":"18","author":"Chirivi","year":"2021","journal-title":"Cell Mol Immunol"},{"key":"10.1136\/ard-2023-224103_bib108","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1002\/art.42679","article-title":"Anti-citrullinated protein antibodies with multiple specificities ameliorate collagen antibody-induced arthritis in a time-dependent manner","volume":"76","author":"Gomez","year":"2024","journal-title":"Arthritis Rheumatol"}],"container-title":["Annals of the Rheumatic Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0003496724000815?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0003496724000815?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/ard-2023-224103","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,5]],"date-time":"2025-01-05T06:02:35Z","timestamp":1736056955000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0003496724000815"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,7]]},"references-count":107,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2024,7]]}},"alternative-id":["S0003496724000815"],"URL":"https:\/\/doi.org\/10.1136\/ard-2023-224103","relation":{},"ISSN":["0003-4967"],"issn-type":[{"value":"0003-4967","type":"print"}],"subject":[],"published":{"date-parts":[[2024,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Immune response to post-translationally modified proteins in rheumatoid arthritis: what makes it special?","name":"articletitle","label":"Article Title"},{"value":"Annals of the Rheumatic Diseases","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1136\/ard-2023-224103","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2024 \u00a9 Author(s) (or their employer(s)) 2024. No commercial re-use. See rights and permissions. Published by Elsevier Inc. on behalf of EULAR. Published by Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}